Hybrid Conferencee

International Conference on Cancer Pathology (ICCPATH - 26)

17th - 18th October 2026 | Amsterdam, Netherlands

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Amsterdam. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Amsterdam event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Amsterdam conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Amsterdam, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Amsterdam."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Cancer Diagnostics

This track will explore the latest innovations in cancer diagnostic techniques, focusing on the integration of histopathology and molecular oncology. Emphasis will be placed on the role of advanced imaging and biomarker discovery in enhancing diagnostic accuracy.

Track 02

Tumor Markers: Clinical Applications and Challenges

This session will examine the clinical utility of tumor markers in cancer diagnosis and monitoring. Discussions will include the challenges associated with the specificity and sensitivity of these biomarkers in various cancer types.

Track 03

Immunohistochemistry in Cancer Pathology

This track will delve into the applications of immunohistochemistry in the characterization of tumors. Participants will discuss the latest techniques and their implications for personalized medicine.

Track 04

Molecular Oncology: Pathways and Targets

This session will focus on the molecular mechanisms underlying cancer pathogenesis and the identification of novel therapeutic targets. Researchers will present findings on signaling pathways and their relevance to tumor biology.

Track 05

Translational Research in Cancer Pathology

This track will highlight the importance of translational research in bridging laboratory findings with clinical applications. Presentations will cover recent breakthroughs that have the potential to impact patient care.

Track 06

Histopathological Techniques and Innovations

This session will showcase cutting-edge histopathological techniques that enhance the understanding of cancer morphology. Participants will discuss the implications of these innovations for diagnostic pathology.

Track 07

Clinical Trials: Emerging Therapies in Oncology

This track will focus on the design and outcomes of recent clinical trials evaluating novel cancer therapies. Discussions will include the role of pathology in trial design and patient stratification.

Track 08

Biomarker Discovery: Challenges and Opportunities

This session will explore the current landscape of biomarker discovery in cancer research. Participants will discuss the methodologies employed and the potential for biomarkers to revolutionize cancer treatment.

Track 09

Disease Mechanisms in Cancer Progression

This track will investigate the underlying mechanisms that drive cancer progression and metastasis. Researchers will present their findings on genetic, epigenetic, and environmental factors influencing disease outcomes.

Track 10

Integrative Approaches in Cancer Pathology

This session will emphasize the importance of integrative approaches combining histopathology, genomics, and proteomics in understanding cancer. Discussions will focus on how these multidisciplinary strategies can enhance diagnostic and therapeutic outcomes.

Track 11

Future Directions in Cancer Pathology Research

This track will provide a platform for discussing future research directions in cancer pathology. Participants will explore emerging trends, technologies, and collaborative efforts aimed at advancing the field.